Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Matt Pietras CFO background - extensive
View:
Post by LithLover on Aug 03, 2021 7:09pm

Matt Pietras CFO background - extensive

Quite the bio for Matt Pietras:

He comes to Stagezero from the position of VP of Finance for CiVi Biopharma

CiVi Biopharma is a privately held company that was founded in 2017. 

To date, the Company has raised approximately ~$120 million and is supported by leading venture and corporate investors, including Boxer Capital, Tang Capital, Roche Ventures, RA Capital and a leading NYC-based biotechnology investment fund.

---------------

Prior to that he was the Controller at Viela Bio

Viela Bio was a spin off of AstraZeneca and was recently purchased for $3 Billion by Horizon Therapeutics

https://www.biopharmadive.com/news/horizon-acquires-astrazeneca-spinout-viela-bio/594265/

-----------

Prior to Viela Bio he was the Therapeutic Area Finance Director- Oncology at AstraZeneca and Head of Financial Planning at Medimmune (an AstraZeneca company).

---------------

Prior to that he was VP Finance Oversight for 8 years at Wells Fargo



Pretty good resume and I'm sure he looked at the future of Stagezero, the Care deal and the financials before he came over to Stagezero.   Welcome aboard.
Comment by capebretongirl on Aug 03, 2021 7:50pm
Impressive resume and experience here and indicates confidence in SZ. Of course now we can expect a scathing rant from our local expert 4everposting of of how Mr Pietras has been banished from the healthcare industry, forced out of various positions and left with the only option of employment with Stage. Such is the plight of the board these days..........
Comment by Liked2Think on Aug 03, 2021 9:10pm
Hopefully he is a get it done kind of guy.  I have put alot of faith in people in high level positions because I thought they had a good resume or worried about being sucessfull but I really think it just comes down to making money for them or looking to be the "big guy on top of the pyramid".  The first company I worked for was a great family grown buisness over the course of ...more  
Comment by LithLover on Aug 03, 2021 9:55pm
Man you are a real half empty kind of guy.  Cheer up.  It will be OK.
Comment by Liked2Think on Aug 03, 2021 11:18pm
I will cheer up when this stock is only down 25% instead of 75 deal?
Comment by LithLover on Aug 04, 2021 12:24am
Deal.    
Comment by Mykndrsn on Aug 04, 2021 8:32am
Hopefully you get back even, sell and be gone forever.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities